Atlantic Research Group

ARG is now part of Evestia Clinical. Follow Evestia Clinical's page to stay connected with our experienced team, our insights and opportunities in trial development. The new organization forms a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering. ARG, founded in 2004, is a contract research organization focused on oncology, immunology, and neurology, providing comprehensive clinical program development services ranging from planning to commercialization, and achieving over 50 market authorizations to date. Built on the vision that every project should be highly individualized, ARG has experienced consistent global growth, expanding its range to include drug and device strategic consulting, clinical trial management services, and advanced clinical data and analytic solutions. ARG uses first-in-class technology platforms along with relationship-driven flexibility to optimize clinical studies, because we believe everyone deserves to be well.